MDT - Silk Road Medical Seeks Continued Growth Amid High Operating Losses
Short Take
Silk Road Medical (SILK) went public on April 4, 2019 and recently reported calendar year 2019 financial results.
The firm produces carotid artery medical devices to protect patients from stroke.
SILK expects strong growth in 2020, but that may be attenuated by unforeseen effects from the Covid-19 virus on hospital operations in major markets.
Given continuing large operating losses and no apparent path to operating profitability, my bias on the stock is Neutral until we know Q1 and Q2 2020’s results.
Company
Sunnyvale, California-based Silk Road Medical was founded in 2007